Does dysregulated complement activation contribute to haemolytic uraemic syndrome secondary to streptococcus pneumoniae?

Medical Hypotheses

Volumn 81, Issue 3, 2013, Pages 400-403

  Gilbert, Rodney D ^a   Nagra, Arvind ^a   Haq, Mushfequr R ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; AMLODIPINE; AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; CLARITHROMYCIN; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; CREATININE; ECULIZUMAB; MEMBRANE COFACTOR PROTEIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHILD; COMPLEMENT ACTIVATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFANT; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIGENS, CD46; COMPLEMENT ACTIVATION; COMPLEMENT C3; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; MALE; PNEUMOCOCCAL INFECTIONS;

EID: 84881555729     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.05.030     Document Type: Article

References (30)

1. Ruggenenti P., Noris M., Remuzzi G. Thrombotic icroangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 2001, 60:831-846.
2. Altschule M.D. A rare type of acute thrombocytopenic purpura: widespread formation of platelet thrombi in capillaries. N Engl J Med 1942, 227:477-479.
3. Obeidat M., Obeidat M., Ballermann B.J. Glomerular endothelium: a porous sieve and formidable barrier. Exp Cell Res 2012, 318:964-972.
4. Keir L., Coward R.J.M. Advances in our understanding of glomerular thrombotic microangiopathy. Pediatr Nephrol 2011, 26:523-533.
5. Loirat C., Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 2011, 6:60.
6. Johnson S., Waters A. Is complement a culprit in infection-induced forms of haemolytic uraemic syndrome?. Immunobiology 2012, 217:235-243.
7. Ståhl A., Sartz L., Karpman D. Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli - induced hemolytic uremic syndrome. Blood 2011, 117:5503-5513.
8. Waters A.M., Kerecuk L., Luk D., et al. Hemolytic uremic syndrome associated with invasive pneumococcal disease: The United Kingdom experience. J Pediatr 2007, 151:140-144.
9. Sutor G.C., Schmidt R.E., Albrecht H. Thrombotic microangiopathies and HIV infection: report of two typical cases, features of HUS and TTP, and review of the literature. Infection 1999, 27:12-15.
10. Caltik A., Akyüz S.G., Erdogan O., Demircin G. Hemolytic uremic syndrome triggered with a new pandemic virus: influenza A (H1N1). Pediatr Nephrol 2011, 26:147-148.
11. Zakarija A., Bennett C. Drug induced thrombotic microangiopathy. Semin Thromb Hemost 2005, 31:681-690.
12. Menni F., Testa S., Guez S., Chiarelli G., Alberti L., Esposito S. Neonatal atypical hemolytic uremic syndrome due to methylmalonic aciduria and homocystinuria. Pediatr Nephrol 2012, 27:1401-1405.
13. Johnson S.A., Williams J.M., Morgan B., Taylor C., Savage C.O.S. Evidence for complement dysregulation in pneumococcal haemolytic uraemic syndrome (Abstract). Pediatr Nephrol 2009, 24:1781.
14. Copelovitch L., Kaplan B.S. Streptococcus pneumoniae-associated hemolytic uremic syndrome. Pediatr Nephrol 2008, 11:1951-1956.
15. Crookston K.P., Reiner A.P., Cooper L.J., Sacher R.A., Blajchman M.A., Heddle N.M. RBC T activation and hemolysis: implications for pediatric transfusion management. Transfusion 2000, 40:801-812.
16. Eber S.W., Polster H., Quentin S.H., Rumpf K.W., Lynen R. Hemolytic uremic syndrome in pneumococcal meningitis and infection. Importance of T-transformation. Monatsschr Kinderheilkd 1993, 141:219-222.
17. Devine D.V. The regulation of complement on cell surfaces. Transfus Med Rev 1991, 5:123-131.
18. Rodriguez de Cordoba S., Esparza-Gordillo J., Goicoechea de Jorge E., Lopez-Trascasa M., Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 2004, 41:355-367.
19. Richards A., Kavanagh D., Atkinson J.P. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory states: the examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration. Adv Immunol 2007, 96:141-177.
20. Hocking H.G., Herbert A.P., Kavanagh D., et al. Structure of the N-terminal region of complement factor H and conformational implications of disease-linked sequence variations. J Biol Chem 2008, 283:9475-9487.
21. Kajander T., Lehtinen M.J., Hyvärinen S., et al. Dual interaction of factor H with C3d and glycosaminoglycan in host-nonhost discrimination by complement. Proc Natl Acad Sci USA 2011, 108:2897-2902.
22. Schmidt C.Q., Herbert A.P., Kavanagh D., et al. A new map of glycosaminoglycan and C3b binding sites on factor H. J Immunol 2008, 181:2610-2619.
23. Hellwage J., Jokiranta T.S., Friese M.A., et al. Complement C3b/C3d and cell surface polyanions are recognised by overlapping binding sites on the most carboxyl-terminal domain of complement factor H. J Immunol 2002, 169:6935-6944.
24. Morgan H.P., Schmidt C.Q., Guariento M., et al. Structural basis for engagement by complement factor H of C3b on a self surface. Nat Struct Mol Biol 2011, 18:463-470.
25. Neumann H.P., Salzmann M., Bohnert-Iwan B., et al. Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. J Med Genet 2003, 40:676-681.
26. Lehtinen M.J., Rops A.L., Isenman D.E., van der Vlag J., Jokiranta T.S. Mutations of factor H Impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome. J Biol Chem 2009, 284:15650-15658.
27. Quin L., Carmicle S., Dave S., Pangburn M.K., Evenhuis J.P., McDaniel L.S. In vivo binding of complement regulatory factor H by Streptococcus pneumoniae. J Infect Dis 2005, 192:1996-2003.
28. Zipfel P.F., Hallström T., Hammerschmidt S., Skerka C. The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci. Vaccine 2008, 30(26 Suppl. 8):167-174.
29. Quin L., Moore Q.C., Thornton J.A., McDaniel L.S. Peritoneal challenge modulates expression of pneumococcal surface protein C during bacteremia in mice. Infect Immun 2008, 76:1122-1127.
30. Dragon-Durey M.-A., Loirat C., Cloarec S., et al. Anti-factor H autoantibodies associated with atypical haemolytic uremic syndrome. J Am Soc Nephrol 2005, 16:555-563.